HHS pledges $23M to develop Merck's experimental Ebola vaccine

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 23, 2019 at 12:22 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,741
    Likes Received:
    3
    via In response to the Ebola outbreak in the Democtratic Republic of Congo, HHS will fund the development of Merck's investigational Ebola vaccine.

    The department will give Merck $23 million to produce V920 doses over the next year and will work with the drugmaker to help secure FDA approval for the vaccine.

    article source